Back
Edgewise Therapeutics Stock Price Chart
Buy
53
EWTX
Edgewise Therapeutics
Last Price:
16.72
Seasonality Move:
-4.2%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EWTX is experiencing selling pressure, which indicates risk of future bearish movement.
Edgewise Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.22 | Sell |
20-day SMA: | 17.32 | Sell |
50-day SMA: | 17.5 | Sell |
200-day SMA: | 12.68 | Buy |
8-day EMA: | 17.11 | Sell |
20-day EMA: | 17.37 | Sell |
50-day EMA: | 17.36 | Sell |
200-day EMA: | 14.14 | Buy |
Edgewise Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.21 | Sell |
Relative Strength Index (14 RSI): | 46.46 | Sell |
Chaikin Money Flow: | -676466 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.97 - 18.03) | Sell |
Bollinger Bands (100): | (16.29 - 18.69) | Sell |
Edgewise Therapeutics Technical Analysis
Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Edgewise Therapeutics Stock
Is Edgewise Therapeutics Stock a Buy?
- Edgewise Therapeutics share price is 17.05 while EWTX 8-day simple moving average is 17.22, which is a Sell signal.
- The stock price of EWTX is 17.05 while Edgewise Therapeutics 20-day SMA is 17.32, which makes it a Sell.
- Edgewise Therapeutics 50-day simple moving average is 17.50 while EWTX share price is 17.05, making it a Sell technically.
- EWTX stock price is 17.05 and Edgewise Therapeutics 200-day simple moving average is 12.68, creating a Buy signal.
EWTX Technical Analysis vs Fundamental Analysis
Buy
53
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy or a Sell?
-
Edgewise Therapeutics stock is rated a Buy
The current Edgewise Therapeutics [EWTX] share price is $17.05. The Score for EWTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Edgewise Therapeutics Stock Info
Market Cap:
1.59B
Price in USD:
17.05
Share Volume:
757.24K
Edgewise Therapeutics 52-Week Range
52-Week High:
21.60
52-Week Low:
5.12
Buy
53
Edgewise Therapeutics (EWTX)
is a Buy
Edgewise Therapeutics Share Price Forecast
-
What is the Edgewise Therapeutics stock price today?
The Edgewise Therapeutics stock price is 17.05 USD today. -
Will EWTX stock go up or go down?
Edgewise Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Edgewise Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Edgewise Therapeutics is not overvalued.
Is Edgewise Therapeutics Stock a Buy?
- Edgewise Therapeutics share price is 17.05 while EWTX 8-day exponential moving average is 17.11, which is a Sell signal.
- The stock price of EWTX is 17.05 while Edgewise Therapeutics 20-day EMA is 17.37, which makes it a Sell.
- Edgewise Therapeutics 50-day exponential moving average is 17.36 while EWTX share price is 17.05, making it a Sell technically.
- EWTX stock price is 17.05 and Edgewise Therapeutics 200-day simple moving average is 14.14, creating a Buy signal.
Fundamental Analysis of Edgewise Therapeutics
Is Edgewise Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.39 per share.
Technical Analysis of Edgewise Therapeutics
Should I short Edgewise Therapeutics stock?
- EWTX Moving Average Covergence Divergence (MACD) indicator is -0.21, suggesting Edgewise Therapeutics is a Sell
- Edgewise Therapeutics Relative Strength Index (RSI) is 46.46, which suggest Edgewise Therapeutics is oversold
- The Bollinger Bands (25) for Edgewise Therapeutics is (16.97 - 18.03), which suggest Edgewise Therapeutics is a Sell
- The Bollinger Bands (100) for Edgewise Therapeutics is (16.29 - 18.69), which suggest Edgewise Therapeutics is a Sell
* Edgewise Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.